Similarly, the infarction volumes were reduced to 22.5% in LMP2-shRNA group compared with Cont-shRNA group (39.7%, infarction volumes/total ipsilateral hemispheric) (*P<0.001, compared with Cont-shRNA group) (Figure 6B,D). The gene discussed is PSMB9; the disease is infarction.